Stopped: The study has stopped after the investigator's decision. The latter desires to analyse the collected data at 60 patients.
Physical exercises program is known to improve quality of life, chronical fatigue and appears to be a behavioural recommendation against cancer as primary and tertiary prevention. Nutritional status is also important in cancer patients: a loss of 5% of weight increases the complication risks and decreases survival and the quality of life. Interactions between physical activity and haematological malignancies are less described compared to solid cancers. Methodology and protocols are also heterogeneous. Supervised exercises program improves the physical condition and the quality of life; however there are few randomised studies versus a controlled group. Post autograft evaluation for myeloma patients showed a physical deficit with increased fat mass, but in this particular population physical exercises need to be more explored. This project is a randomised study versus controlled group that evaluates supervised physical exercises program in a homogenous population: patients under-65-years-old with multiple myeloma and who will undergo autologous stem cell transplantation.
Age range
18 Years – 65 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Measure of quality of life with EORTC QLQ-C30 questionnaire
Timeframe: at day 0 from autograft as patient will be hospitalized.
Measure of quality of life with EORTC QLQ-C30 questionnaire
Timeframe: at day 30 from autograft as patient will be hospitalized.
Measure of quality of life with EORTC QLQ-C30 questionnaire
Timeframe: at day 90 from autograft as patient will be hospitalized.
Measure of quality of life with QLQ-MY20 questionnaire
Timeframe: at day 0 from autograft as patient will be hospitalized.
Measure of quality of life measured with QLQ-MY20 questionnaire
Timeframe: at day 30 from autograft as patient will be hospitalized.
Measure of quality of life measured with QLQ-MY20 questionnaire
Timeframe: at day 90 from autograft as patient will be hospitalized.